Potentiation of GluN2C/D NMDA receptor subtypes in the amygdala facilitates the retention of fear and extinction learning in mice

Neuropsychopharmacology

Volumn 39, Issue 3, 2014, Pages 625-637

  Ogden, Kevin K ^a   Khatri, Alpa ^a   Traynelis, Stephen F ^a   Heldt, Scott A ^b,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Anatomy and Neurobiology ^*  (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

D cycloserine; extinction; fear; GluN2C; GluN2D; NMDA

Indexed keywords

CYCLOSERINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2C; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2D; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASOLATERAL AMYGDALA; CONDITIONING; CONTROLLED STUDY; DRUG ACTIVITY; FEAR; LEARNING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT;

AMYGDALA; ANIMALS; AREA UNDER CURVE; BENZIMIDAZOLES; CONDITIONING (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; EXTINCTION, PSYCHOLOGICAL; FEAR; GENE EXPRESSION REGULATION; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROINJECTIONS; MOTOR ACTIVITY; OOCYTES; RECEPTORS, N-METHYL-D-ASPARTATE; RETENTION (PSYCHOLOGY); XENOPUS;

EID: 84892674051     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2013.241     Document Type: Article

References (87)

1. Akazawa C, Shigemoto R, Bessho Y, Nakanishi S, Mizuno N (1994). Differential expression of five N-methyl-D-aspartate receptor subunit mRNAs in the cerebellum of developing and adult rats. J Comp Neurol 347: 150-160.
2. Assini FL, Duzzioni M, Takahashi RN (2009). Object location memory in mice: Pharmacological validation and further evidence of hippocampal CA1 participation. Behav Brain Res 204: 206-211.
3. Aura J, Riekkinen M, Riekkinen P Jr (1998). Tetrahydroaminoacridine and d-cycloserine stimulate acquisition of water maze spatial navigation in aged rats. Eur J Pharmacol 342: 15-20.
4. Bado P, Madeira C, Vargas-Lopes C, Moulin TC, Wasilewska-Sampaio AP, Maretti L et al (2011). Effects of low-dose D-serine on recognition and working memory in mice. Psychopharmacology 218: 461-470.
5. Baker JD, Azorlosa JL (1996). The NMDA antagonist MK-801 blocks the extinction of Pavlovian fear conditioning. Behav Neurosci 110: 618-620.
6. Bauer EP, Schafe GE, LeDoux JE (2002). NMDA receptors and L-type voltage-gated calcium channels contribute to long-term potentiation and different components of fear memory formation in the lateral amygdala. J Neurosci 22: 5239-5249.
7. Bombardi C (2011). Distribution of 5-HT2A receptor immunoreactivity in the rat amygdaloid complex and colocalization with g-aminobutyric acid. Brain Res 1370: 112-128.
8. Bombardi C, Di Giovanni G (2013). Functional anatomy of 5-HT receptors in the amygdala and hippocampal complex: relevance to memory functions. Exp Brain Res doi:10.1007/s00221-013-3512-6.
9. Bruchas MR, Land BB, Lemos JC, Chavkin C (2009). CRF1-R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior. PloS One 4: e8528.
10. Butelman ER, Yuferov V, Kreek MJ (2012). k-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction. Trends Neurosci 35: 587-596.
11. Carr GV, Lucki I (2010). Comparison of the kappa-opioid receptor antagonist DIPPA in tests of anxiety-like behavior between Wistar Kyoto and Sprague Dawley rats. Psychopharmacology 210: 295-302.
12. Chen A, Hough CJ, Li H (2003). Serotonin type II receptor activation facilitates synaptic plasticity via n-methyl-d-aspartatemediated mechanism in the rat basolateral amygdala. Neuroscience 119: 53-63.
13. Clem RL, Huganir RL (2010). Calcium-permeable AMPA receptor dynamics mediate fear memory erasure. Science 330: 1108-1112.
14. Cryan JF, Sweeney FF (2011). The age of anxiety: role of animal models of anxiolytic action in drug discovery. Br J Pharmacol 164: 1129-1161.
15. Dalton GL, Wu DC, Wang YT, Floresco SB, Phillips AG (2012). NMDA GluN2A and GluN2B receptors play separate roles in the induction of LTP and LTD in the amygdala and in the acquisition and extinction of conditioned fear. Neuropharmacology 62: 797-806.
16. Dravid SM, Burger PB, Prakash A, Geballe MT, Yadav R, Le P et al (2010). Structural determinants of D-cycloserine efficacy at the NR1/NR2C NMDA receptors. J Neurosci 30: 2741-2754.
17. Eison AS, Mullins UL (1995). Regulation of central 5-HT2A receptors: a review of in vivo studies. Behav Brain Res 73: 177-181.
18. Fallon JH, Leslie FM (1986). Distribution of dynorphin and enkephalin peptides in the rat brain. J Comp Neurol 249: 293-336.
19. Falls WA, Miserendino MJ, Davis M (1992). Extinction of fearpotentiated startle: blockade by infusion of an NMDA antagonist into the amygdala. J Neurosci 12: 854-863.
20. Flood JF, Morley JE, Lanthorn TH (1992). Effect on memory processing by D-cycloserine, an agonist of the NMDA/glycine receptor. Eur J Pharmacol 221: 249-254.
21. Gladding CM, Raymond LA (2011). Mechanisms underlying NMDA receptor synaptic/extrasynaptic distribution and function. Mol Cell Neurosci 48: 308-320.
22. Graham BM, Langton JM, Richardson R (2011). Pharmacological enhancement of fear reduction: preclinical models. Br J Pharmacology 164: 1230-1247.
23. Gray JA, Shi Y, Usui H, During MJ, Sakimura K, Nicoll RA (2011). Distinct modes of AMPA receptor suppression at developing synapses by GluN2A and GluN2B: single-cell NMDA receptor subunit deletion in vivo. Neuron 71: 1085-1101.
24. Heldt SA, Ressler KJ (2006). Lesions of the habenula produce stress-and dopamine-dependent alterations in prepulse inhibition and locomotion. Brain Res 1073-1074: 229-239.
25. Hillman BG, Gupta SC, Stairs DJ, Buonanno A, Dravid SM (2011). Behavioral analysis of NR2C knockout mouse reveals deficit in acquisition of conditioned fear and working memory. Neurobiol Learn Mem 95: 404-414.
26. Hollmann M, Heinemann S (1994). Cloned glutamate receptors. Annu Rev Neurosci 17: 31-108.
27. Homberg JR (2012). Serotonergic modulation of conditioned fear. Scientifica 2012: 16.
28. Huge V, Rammes G, Beyer A, Zieglgänsberger W, Azad SC (2009). Activation of kappa opioid receptors decreases synaptic transmission and inhibits long-term potentiation in the basolateral amygdala of the mouse. Eur J Pain 13: 124-129.
29. Jamensky NT, Gianoulakis C (1997). Content of Dynorphins and k-Opioid Receptors in Distinct Brain Regions of C57BL/6 and DBA/2 Mice. Alcohol Clin Exp Research 21: 1455-1464.
30. Johansen JP, Cain CK, Ostroff LE, LeDoux JE (2011). Molecular mechanisms of fear learning and memory. Cell 147: 509-524.
31. Jones SV, Heldt SA, Davis M, Ressler KJ (2005). Olfactorymediated fear conditioning in mice: simultaneous measurements of fear-potentiated startle and freezing. Behav Neurosci 119: 329-335.
32. Kalisch R, Holt B, Petrovic P, De Martino B, Kloppel S, Buchel C et al (2009). The NMDA agonist D-cycloserine facilitates fear memory consolidation in humans. Cerebral cortex 19: 187-196.
33. Karavanova I, Vasudevan K, Cheng J, Buonanno A (2007). Novel regional and developmental NMDA receptor expression patterns uncovered in NR2C subunit-beta-galactosidase knock-in mice. Mol Cell Neurosci 34: 468-480.
34. King MV, Marsden CA, Fone KC (2008). A role for the 5-HT(1A), 5-HT4 and 5-HT6 receptors in learning and memory. Trends Pharmacol Sci 29: 482-492.
35. Knoll AT, Meloni EG, Thomas JB, Carroll FI, Carlezon WA (2007). Anxiolytic-like effects of k-opioid receptor antagonists in models of unlearned and learned fear in rats. J Pharmacol Exp Ther 323: 838-845.
36. Knoll AT, Muschamp JW, Sillivan SE, Ferguson D, Dietz DM, Meloni EG et al (2011). Kappa opioid receptor signaling in the basolateral amygdala regulates conditioned fear and anxiety in rats. Biol Psychiatry 70: 425-433.
37. Korotkova T, Fuchs EC, Ponomarenko A, von Engelhardt J, Monyer H (2010). NMDA receptor ablation on parvalbuminpositive interneurons impairs hippocampal synchrony, spatial representations, and working memory. Neuron 68: 557-569.
38. Kuzmin A, Madjid N, Terenius L, Ogren SO, Bakalkin G (2006). Big dynorphin, a prodynorphin-derived peptide produces NMDA receptor-mediated effects on memory, anxiolytic-like and locomotor behavior in mice. Neuropsychopharmacology 31: 1928-1937.
39. Land C, Riccio DC (1999). d-Cycloserine: effects on long-term retention of a conditioned response and on memory for contextual attributes. Neurobiol Learn Mem 72: 158-168.
40. Ledgerwood L, Richardson R, Cranney J (2003). Effects of D-cycloserine on extinction of conditioned freezing. Behav Neurosci 117: 341-349.
41. Lee H, Kim JJ (1998). Amygdalar NMDA receptors are critical for new fear learning in previously fear-conditioned rats. J Neurosci 18: 8444-8454.
42. Li H, Penzo MA, Taniguchi H, Kopec CD, Huang ZJ, Li B (2013). Experience-dependent modification of a central amygdala fear circuit. Nat Neurosci 16: 332-339.
43. Lin C-H, Yeh S-H, Lu H-Y, Gean P-W (2003). The similarities and diversities of signal pathways leading to consolidation of conditioning and consolidation of extinction of fear memory. J Neurosci 23: 8310-8317.
44. Lindner MD, Hodges DB Jr, Hogan JB, Orie AF, Corsa JA, Barten DM et al (2003). An assessment of the effects of serotonin 6 (5-HT6) receptor antagonists in rodent models of learning. J Pharmacol Exp Ther 307: 682-691.
45. Mansour A, Fox CA, Akil H, Watson SJ (1995). Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci 18: 22-29.
46. McDonald AJ, Mascagni F (2007). Neuronal localization of 5-HT type 2A receptor immunoreactivity in the rat basolateral amygdala. Neuroscience 146: 306-320.
47. McKernan MG, Shinnick-Gallagher P (1997). Fear conditioning induces a lasting potentiation of synaptic currents in vitro. Nature 390: 607-611.
48. McNally GP (2009). The roles of endogenous opioids in fear learning. Int J Comparative Psychol 22: 153-169.
49. Miserendino MJ, Sananes CB, Melia KR, Davis M (1990). Blocking of acquisition but not expression of conditioned fear-potentiated startle by NMDA antagonists in the amygdala. Nature 345: 716-718.
50. Mitchell ES, Neumaier JF (2005). 5-HT6 receptors: a novel target for cognitive enhancement. Pharmacol Ther 108: 320-333.
51. Mitchell ES, Neumaier JF (2008). 5-HT6 receptor antagonist reversal of emotional learning and prepulse inhibition deficits induced by apomorphine or scopolamine. Pharmacol, Biochem-Behav 88: 291-298.
52. Monaghan DT, Irvine MW, Costa BM, Fang G, Jane DE (2012). Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators. Neurochem Int 61: 581-592.
53. Monahan JB, Handelmann GE, Hood WF, Cordi AA (1989). D-cycloserine, a positive modulator of the N-methyl-D-aspartate receptor, enhances performance of learning tasks in rats. Pharmacol Biochem Behavi 34: 649-653.
54. Montezinho LP, Miller S, Plath N, Jensen NH, Karlsson JJ, Witten L et al (2010). The effects of acute treatment with escitalopram on the different stages of contextual fear conditioning are reversed by atomoxetine. Psychopharmacology 212: 131-143.
55. Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH (1994). Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12: 529-540.
56. Mullasseril P, Hansen KB, Vance KM, Ogden KK, Yuan H, Kurtkaya NL et al (2010). A subunit-selective potentiator of NR2Cand NR2D-containing NMDA receptors. Nat Commun 1: 90.
57. Myers KM, Carlezon WA Jr., Davis M (2011). Glutamate receptors in extinction and extinction-based therapies for psychiatric illness. Neuropsychopharmacology 36: 274-293.
58. Myers KM, Davis M (2007). Mechanisms of fear extinction. Mol Psychiatry 12: 120-150.
59. Ogden KK, Traynelis SF (2011). New advances in NMDA receptor pharmacology. Trends Pharmacol Sci 32: 726-733.
60. Paoletti P, Bellone C, Zhou Q (2013). NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci 14: 383-400.
61. Paxinos G, Franklin K (2001). The Mouse Brain in Stereotaxic Coordinates. Academic Press: New York, NY, USA.
62. Pitkanen M, Sirvio J, MacDonald E, Ekonsalo T, Riekkinen P Sr. (1995). The effects of d-cycloserine, a partial agonist at the glycine binding site, on spatial learning and working memory in scopolamine-treated rats. J Neural Transm Park Dis Dement Sec 9: 133-144.
63. Rainnie DG (1999). Serotonergic Modulation of Neurotransmission in the Rat Basolateral Amygdala. J Neurophysiol 82: 69-85.
64. Research IoLA, Sciences CoL, Council NR (1996). Guide for the Care and Use of Laboratory Animals. The National Academies Press: Washington, D.C., USA.
65. Rodrigues SM, Schafe GE, LeDoux JE (2001). Intra-amygdala blockade of the NR2B subunit of the NMDA receptor disrupts the acquisition but not the expression of fear conditioning. J Neurosci 21: 6889-6896.
66. Rogan MT St, ubli UV, LeDoux JE (1997). Fear conditioning induces associative long-term potentiation in the amygdala. Nature 390: 604-607.
67. Santangelo Freel RM, Ogden KK, Strong KL, Khatri A, Chepiga KM, Jensen HS (2013). Synthesis and structure activity relationship of tetrahydroisoquinoline-based potentiators of GluN2C and GluN2D containing N-Methyl-D-Aspartate receptors. J Med Chem 56: 5351-5381.
68. Santini E, Muller RU, Quirk GJ (2001). Consolidation of extinction learning involves transfer from NMDA-independent to NMDAdependent memory. J Neurosci 21: 9009-9017.
69. Sanz-Clemente A, Nicoll RA, Roche KW (2013). Diversity in NMDA receptor composition: many regulators, many consequences. Neuroscientist 19: 62-75.
70. Schroeder BW, Shinnick-Gallagher P (2004). Fear memories induce a switch in stimulus response and signaling mechanisms for long-term potentiation in the lateral amygdala. Eur J Neurosci 20: 549-556.
71. Schroeder BW, Shinnick-Gallagher P (2005). Fear learning induces persistent facilitation of amygdala synaptic transmission. Eur J Neurosci 22: 1775-1783.
72. Sheinin A, Shavit S, Benveniste M (2001). Subunit specificity and mechanism of action of NMDA partial agonist D-cycloserine. Neuropharmacology 41: 151-158.
73. Smith JS, Schindler AG, Martinelli E, Gustin RM, Bruchas MR, Chavkin C (2012). Stress-induced activation of the dynorphin/kappa-opioid receptor system in the amygdala potentiates nicotine conditioned place preference. J Neurosci 32: 1488-1495.
74. Sobolevsky AI, Rosconi MP, Gouaux E (2009). X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor. Nature 462: 745-756.
75. Sokal DM, Giarola AS, Large CH (2005). Effects of GABAB, 5-HT1A, and 5-HT2 receptor stimulation on activation and inhibition of the rat lateral amygdala following medial geniculate nucleus stimulation in vivo. Brain Res 1031: 141-150.
76. Standaert DG, Testa CM, Young AB, Penney JB Jr (1994). Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat. J Comp Neurol 343: 1-16.
77. Stein C, Davidowa H, Albrecht D (2000). 5-HT(1A) receptormediated inhibition and 5-HT(2) as well as 5-HT(3) receptormediated excitation in different subdivisions of the rat amygdala. Synapse 38: 328-337.
78. Sunyer B, Patil S, Frischer C, Hoeger H, Lubec G (2008). Straindependent effects of cognitive enhancers in the mouse. Amino Acids 34: 485-495.
79. Suzuki A, Josselyn SA, Frankland PW, Masushige S, Silva AJ, Kida S (2004). Memory reconsolidation and extinction have distinct temporal and biochemical signatures. J Neurosci 24: 4787-4795.
80. Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK et al (2010). Glutamate receptor ion channels: structure, regulation, and function. Pharamacol Rev 62: 405-496.
81. Tsvetkov E, Carlezon WA, Benes FM, Kandel ER, Bolshakov VY (2002). Fear conditioning occludes LTP-induced presynaptic enhancement of synaptic transmission in the cortical pathway to the lateral amygdala. Neuron 34: 289-300.
82. Ulbrich MH, Isacoff EY (2008). Rules of engagement for NMDA receptor subunits. Proc Natl Acad Sci USA 105: 14163-14168.
83. Walker DL, Davis M (2008). Amygdala infusions of an NR2Bselective or an NR2A-preferring NMDA receptor antagonist differentially influence fear conditioning and expression in the fear-potentiated startle test. Learn Mem 15: 67-74.
84. Walker DL, Ressler KJ, Lu KT, Davis M (2002). Facilitation of conditioned fear extinction by systemic administration or intraamygdala infusions of D-cycloserine as assessed with fearpotentiated startle in rats. J Neurosci 22: 2343-2351.
85. Yang YL, Lu KT (2005). Facilitation of conditioned fear extinction by d-cycloserine is mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase cascades and requires de novo protein synthesis in basolateral nucleus of amygdala. Neuroscience 134: 247-260.
86. Zhang G, Asgeirsdottir HN, Cohen SJ, Munchow AH, Barrera MP, Stackman RW Jr. (2013). Stimulation of serotonin 2A receptors facilitates consolidation and extinction of fear memory in C57BL/6J mice. Neuropharmacology 64: 403-413.
87. Zlomuzica A, De Souza Silva MA, Huston JP, Dere E (2007). NMDA receptor modulation by D-cycloserine promotes episodic-like memory in mice. Psychopharmacology 193: 503-509.